Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

CCLD vs PHR

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
CCLD
CareCloud, Inc.

Medical - Healthcare Information Services

HealthcareNASDAQ • US
Market Cap$1.13B
5Y Perf.-54.4%
PHR
Phreesia, Inc.

Medical - Healthcare Information Services

HealthcareNYSE • US
Market Cap$575M
5Y Perf.-67.5%

CCLD vs PHR — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
CCLD logoCCLD
PHR logoPHR
IndustryMedical - Healthcare Information ServicesMedical - Healthcare Information Services
Market Cap$1.13B$575M
Revenue (TTM)$120M$463M
Net Income (TTM)$11M$-5M
Gross Margin34.1%68.2%
Operating Margin9.5%-1.9%
Forward P/E17.1x29.6x
Total Debt$4M$18M
Cash & Equiv.$3M$84M

CCLD vs PHRLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

CCLD
PHR
StockMay 20May 26Return
CareCloud, Inc. (CCLD)10045.6-54.4%
Phreesia, Inc. (PHR)10032.5-67.5%

Price return only. Dividends and distributions are not included.

Quick Verdict: CCLD vs PHR

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: CCLD leads in 5 of 7 categories, making it the strongest pick for valuation and capital efficiency and profitability and margin quality. Phreesia, Inc. is the stronger pick specifically for growth and revenue expansion and capital preservation and lower volatility. As sector peers, any of these can serve as alternatives in the same allocation.
CCLD
CareCloud, Inc.
The Long-Run Compounder

CCLD carries the broadest edge in this set and is the clearest fit for long-term compounding.

  • 199.0% 10Y total return vs PHR's -62.0%
  • Lower P/E (17.1x vs 29.6x)
  • 9.0% margin vs PHR's -1.2%
Best for: long-term compounding
PHR
Phreesia, Inc.
The Income Pick

PHR is the clearest fit if your priority is income & stability and growth exposure.

  • Dividend streak 1 yrs, beta 0.79
  • Rev growth 17.8%, EPS growth 59.4%, 3Y rev CAGR 25.3%
  • Lower volatility, beta 0.79, Low D/E 6.7%, current ratio 1.78x
Best for: income & stability and growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthPHR logoPHR17.8% revenue growth vs CCLD's 8.7%
ValueCCLD logoCCLDLower P/E (17.1x vs 29.6x)
Quality / MarginsCCLD logoCCLD9.0% margin vs PHR's -1.2%
Stability / SafetyPHR logoPHRBeta 0.79 vs CCLD's 1.15, lower leverage
DividendsCCLD logoCCLD0.6% yield; the other pay no meaningful dividend
Momentum (1Y)CCLD logoCCLD+39.7% vs PHR's -60.7%
Efficiency (ROA)CCLD logoCCLD13.2% ROA vs PHR's -1.3%, ROIC 15.9% vs -23.3%

CCLD vs PHR — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

CCLDCareCloud, Inc.
FY 2025
Revenue Cycle Management
80.1%$3M
Remote Patient Monitoring
19.9%$794,000
PHRPhreesia, Inc.
FY 2025
Subscription And Services
46.8%$197M
Network Solutions
29.0%$122M
Payment Processing Fees
24.2%$102M

CCLD vs PHR — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLCCLDLAGGINGPHR

Income & Cash Flow (Last 12 Months)

CCLD leads this category, winning 4 of 5 comparable metrics.

PHR is the larger business by revenue, generating $463M annually — 3.8x CCLD's $120M. CCLD is the more profitable business, keeping 9.0% of every revenue dollar as net income compared to PHR's -1.2%. On growth, CCLD holds the edge at +21.9% YoY revenue growth, suggesting stronger near-term business momentum.

MetricCCLD logoCCLDCareCloud, Inc.PHR logoPHRPhreesia, Inc.
RevenueTrailing 12 months$120M$463M
EBITDAEarnings before interest/tax$28M$20M
Net IncomeAfter-tax profit$11M-$5M
Free Cash FlowCash after capex$29M$42M
Gross MarginGross profit ÷ Revenue+34.1%+68.2%
Operating MarginEBIT ÷ Revenue+9.5%-1.9%
Net MarginNet income ÷ Revenue+9.0%-1.2%
FCF MarginFCF ÷ Revenue+23.7%+9.0%
Rev. Growth (YoY)Latest quarter vs prior year+21.9%+12.7%
EPS Growth (YoY)Latest quarter vs prior year-88.3%
CCLD leads this category, winning 4 of 5 comparable metrics.

Valuation Metrics

PHR leads this category, winning 3 of 5 comparable metrics.
MetricCCLD logoCCLDCareCloud, Inc.PHR logoPHRPhreesia, Inc.
Market CapShares × price$1.1B$575M
Enterprise ValueMkt cap + debt − cash$1.1B$508M
Trailing P/EPrice ÷ TTM EPS29.90x-9.34x
Forward P/EPrice ÷ next-FY EPS est.17.09x29.63x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple40.25x
Price / SalesMarket cap ÷ Revenue9.42x1.37x
Price / BookPrice ÷ Book value/share19.07x2.07x
Price / FCFMarket cap ÷ FCF39.73x69.29x
PHR leads this category, winning 3 of 5 comparable metrics.

Profitability & Efficiency

CCLD leads this category, winning 6 of 9 comparable metrics.

CCLD delivers a 19.0% return on equity — every $100 of shareholder capital generates $19 in annual profit, vs $-2 for PHR. PHR carries lower financial leverage with a 0.07x debt-to-equity ratio, signaling a more conservative balance sheet compared to CCLD's 0.07x. On the Piotroski fundamental quality scale (0–9), PHR scores 6/9 vs CCLD's 4/9, reflecting solid financial health.

MetricCCLD logoCCLDCareCloud, Inc.PHR logoPHRPhreesia, Inc.
ROE (TTM)Return on equity+19.0%-1.7%
ROA (TTM)Return on assets+13.2%-1.3%
ROICReturn on invested capital+15.9%-23.3%
ROCEReturn on capital employed+20.0%-21.7%
Piotroski ScoreFundamental quality 0–946
Debt / EquityFinancial leverage0.07x0.07x
Net DebtTotal debt minus cash$1M-$66M
Cash & Equiv.Liquid assets$3M$84M
Total DebtShort + long-term debt$4M$18M
Interest CoverageEBIT ÷ Interest expense40.06x-1.01x
CCLD leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

CCLD leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in CCLD five years ago would be worth $3,756 today (with dividends reinvested), compared to $1,984 for PHR. Over the past 12 months, CCLD leads with a +39.7% total return vs PHR's -60.7%. The 3-year compound annual growth rate (CAGR) favors CCLD at -0.2% vs PHR's -31.5% — a key indicator of consistent wealth creation.

MetricCCLD logoCCLDCareCloud, Inc.PHR logoPHRPhreesia, Inc.
YTD ReturnYear-to-date+2.7%-41.5%
1-Year ReturnPast 12 months+39.7%-60.7%
3-Year ReturnCumulative with dividends-0.7%-67.9%
5-Year ReturnCumulative with dividends-62.4%-80.2%
10-Year ReturnCumulative with dividends+199.0%-62.0%
CAGR (3Y)Annualised 3-year return-0.2%-31.5%
CCLD leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

Evenly matched — CCLD and PHR each lead in 1 of 2 comparable metrics.

PHR is the less volatile stock with a 0.79 beta — it tends to amplify market swings less than CCLD's 1.15 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CCLD currently trades 74.6% from its 52-week high vs PHR's 29.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricCCLD logoCCLDCareCloud, Inc.PHR logoPHRPhreesia, Inc.
Beta (5Y)Sensitivity to S&P 5001.15x0.79x
52-Week HighHighest price in past year$4.01$32.76
52-Week LowLowest price in past year$1.80$7.77
% of 52W HighCurrent price vs 52-week peak+74.6%+29.1%
RSI (14)Momentum oscillator 0–10044.750.1
Avg Volume (50D)Average daily shares traded548K1.9M
Evenly matched — CCLD and PHR each lead in 1 of 2 comparable metrics.

Analyst Outlook

PHR leads this category, winning 1 of 1 comparable metric.

Wall Street rates CCLD as "Buy" and PHR as "Buy". Consensus price targets imply 181.8% upside for PHR (target: $27) vs 8.7% for CCLD (target: $3). CCLD is the only dividend payer here at 0.55% yield — a key consideration for income-focused portfolios.

MetricCCLD logoCCLDCareCloud, Inc.PHR logoPHRPhreesia, Inc.
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$3.25$26.86
# AnalystsCovering analysts725
Dividend YieldAnnual dividend ÷ price+0.6%
Dividend StreakConsecutive years of raises01
Dividend / ShareAnnual DPS$0.02
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%
PHR leads this category, winning 1 of 1 comparable metric.
Key Takeaway

CCLD leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). PHR leads in 2 (Valuation Metrics, Analyst Outlook). 1 tied.

Best OverallCareCloud, Inc. (CCLD)Leads 3 of 6 categories
Loading custom metrics...

CCLD vs PHR: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is CCLD or PHR a better buy right now?

For growth investors, Phreesia, Inc.

(PHR) is the stronger pick with 17. 8% revenue growth year-over-year, versus 8. 7% for CareCloud, Inc. (CCLD). CareCloud, Inc. (CCLD) offers the better valuation at 29. 9x trailing P/E (17. 1x forward), making it the more compelling value choice. Analysts rate CareCloud, Inc. (CCLD) a "Buy" — based on 7 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — CCLD or PHR?

On forward P/E, CareCloud, Inc.

is actually cheaper at 17. 1x.

03

Which is the better long-term investment — CCLD or PHR?

Over the past 5 years, CareCloud, Inc.

(CCLD) delivered a total return of -62. 4%, compared to -80. 2% for Phreesia, Inc. (PHR). Over 10 years, the gap is even starker: CCLD returned +199. 0% versus PHR's -62. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — CCLD or PHR?

By beta (market sensitivity over 5 years), Phreesia, Inc.

(PHR) is the lower-risk stock at 0. 79β versus CareCloud, Inc. 's 1. 15β — meaning CCLD is approximately 44% more volatile than PHR relative to the S&P 500. On balance sheet safety, Phreesia, Inc. (PHR) carries a lower debt/equity ratio of 7% versus 7% for CareCloud, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — CCLD or PHR?

By revenue growth (latest reported year), Phreesia, Inc.

(PHR) is pulling ahead at 17. 8% versus 8. 7% for CareCloud, Inc. (CCLD). On earnings-per-share growth, the picture is similar: CareCloud, Inc. grew EPS 135. 7% year-over-year, compared to 59. 4% for Phreesia, Inc.. Over a 3-year CAGR, PHR leads at 25. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — CCLD or PHR?

CareCloud, Inc.

(CCLD) is the more profitable company, earning 9. 0% net margin versus -13. 9% for Phreesia, Inc. — meaning it keeps 9. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CCLD leads at 9. 5% versus -13. 8% for PHR. At the gross margin level — before operating expenses — PHR leads at 67. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is CCLD or PHR more undervalued right now?

On forward earnings alone, CareCloud, Inc.

(CCLD) trades at 17. 1x forward P/E versus 29. 6x for Phreesia, Inc. — 12. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PHR: 181. 8% to $26. 86.

08

Which pays a better dividend — CCLD or PHR?

In this comparison, CCLD (0.

6% yield) pays a dividend. PHR does not pay a meaningful dividend and should not be held primarily for income.

09

Is CCLD or PHR better for a retirement portfolio?

For long-horizon retirement investors, CareCloud, Inc.

(CCLD) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 15), 0. 6% yield, +199. 0% 10Y return). Both have compounded well over 10 years (CCLD: +199. 0%, PHR: -62. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between CCLD and PHR?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: CCLD is a small-cap quality compounder stock; PHR is a small-cap high-growth stock. CCLD pays a dividend while PHR does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

CCLD

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 10%
  • Net Margin > 5%
Run This Screen
Stocks Like

PHR

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 6%
  • Gross Margin > 40%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform CCLD and PHR on the metrics below

Revenue Growth>
%
(CCLD: 21.9% · PHR: 12.7%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.